Cargando…
华氏巨球蛋白血症患者的临床特征、MYD88(L265P)、CXCR4(WHIM)突变和预后:单中心93例回顾性分析
OBJECTIVE: To evaluate the clinical characteristics, MYD88(L265P) mutation, CXCR4(WHIM) mutation and prognosis in patients with Waldenström macroglobulinemia (WM). METHODS: The clinical characteristics, International Prognostic Scoring System for symptomatic WM (WPSS), and overall survival (OS) were...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342974/ https://www.ncbi.nlm.nih.gov/pubmed/28655092 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.006 |
Ejemplares similares
-
华氏巨球蛋白血症的临床特征及预后:单中心临床数据报道
Publicado: (2020) -
不同方法和标本检测华氏巨球蛋白血症患者MYD88突变的初步探索
Publicado: (2022) -
巨球蛋白血症患者临床特征和预后并与Pivotal研究比较
Publicado: (2021) -
布鲁顿酪氨酸激酶抑制剂单药治疗初诊华氏巨球蛋白血症患者的疗效和安全性
Publicado: (2023) -
华氏巨球蛋白血症伴中枢神经系统转化型淋巴瘤一例附文献复习
Publicado: (2018)